Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

11.93
-0.0100-0.08%
Post-market: 11.93-0.0070-0.06%17:20 EDT
Volume:4.45M
Turnover:53.12M
Market Cap:8.15B
PE:-17.24
High:12.03
Open:11.90
Low:11.85
Close:11.94
52wk High:13.06
52wk Low:8.73
Shares:682.88M
Float Shares:414.56M
Volume Ratio:0.99
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6921
EPS(LYR):-0.2371
ROE:-18.15%
ROA:-12.59%
PB:1.87
PE(LYR):-50.32

Loading ...

Leerink Partners Keeps Their Buy Rating on Roivant Sciences (ROIV)

TIPRANKS
·
Aug 13

Stock Track | Roivant Sciences Plummets 5.13% as Q1 Losses Exceed Expectations

Stock Track
·
Aug 11

Roivant Sciences Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

Roivant Sciences Q1 Revenue USD 2.17 Million

Reuters
·
Aug 11

Roivant Sciences Q1 2026 Adj. EPS $(0.25) Beats $(0.30) Estimate, Sales $2.170M Down From $7.990M YoY

Benzinga
·
Aug 11

Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q1 Net Loss $0.33 a Share, vs. FactSet Est of $0.28 Loss

MT Newswires Live
·
Aug 11

Roivant Sciences Ltd. Reports Q1 Loss of $223.4M, EPS Declines to $(0.33)

Reuters
·
Aug 11

Roivant Sciences Q1 EPS USD -0.33

THOMSON REUTERS
·
Aug 11

Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update

THOMSON REUTERS
·
Aug 11

Roivant Sciences Ltd. Files Initial Statement of Beneficial Ownership for Frank Torti, President and Vant Chair

Reuters
·
Jul 30

Roivant Sciences Ltd. Announces Date for Annual General Meeting of Shareholders

Reuters
·
Jul 30

Roivant Sciences Ltd. to Announce Financial Results for First Quarter of 2025

Reuters
·
Jul 29

Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025

THOMSON REUTERS
·
Jul 29

Eric Venker, President & Immunovant CEO, Reports Disposal of Common Shares in Roivant Sciences Ltd

Reuters
·
Jul 24

Roivant Sciences resumed with a Buy at Goldman Sachs

TIPRANKS
·
Jul 10

Roivant Sciences (ROIV) Initiated with a Buy at Goldman Sachs

TIPRANKS
·
Jul 10

FACTBOX-US corporate heads who got involved in politics

Reuters
·
Jul 08

BRIEF-Roivant Sciences Authorizes $500 Million Share Repurchase Program

Reuters
·
Jun 25

Eric Venker, President & COO, Reports Disposal of Roivant Sciences Ltd. Common Shares

Reuters
·
Jun 25

Vivek Ramaswamy, 10% Owner, Reports Disposal of Common Shares in Roivant Sciences Ltd

Reuters
·
Jun 23